Search bioRxiv⌕ Search

Biology subjects

Doryab, A.

Publications and source records attributed to Doryab, A..

2 recordsLinked to original sources

CoRhythMo: A Computational Framework for Modeling Biobehavioral Rhythms from Mobile and Wearable Data Streams

This paper presents CoRhythMo, the first computational framework for modeling biobehavioral rhythms - the repeating cycles of physiological, psychological, social, and environmental events - from mobile and wearable data streams. The framework incorporates four main components: mobile data processing, rhythm discovery, rhythm modeling, and machine learning. We use a dataset of smartphone and Fitbit data collected from 138 college students over a semester to evaluate the frameworks ability to 1) model biobehavioral rhythms of students, 2) measure the stability of their rhythms over the course of the semester, 3) model differences between rhythms of students with different health status, and 4) predict the mental health status in students using the model of their biobehavioral rhythms. Our evaluation provides evidence for the feasibility of using CoRhythMo for modeling and discovering human rhythms and using them to assess and predict different life and health outcomes.

bioinformatics↗

Organ-restricted vascular delivery of nanoparticles for lung cancer therapy

Nanomedicines hold immense promise for a number of devastating diseases due to the ability to custom-design both the carrier and cargo. However, their clinical implementation has been hampered by physicochemical and biological barriers and off-target deposition which impair cell specific targeting, especially in internal organs. This study reports a new delivery approach using organ-restricted vascular delivery to allow for direct administration and recirculation of stimuli-responsive nanoparticles to promote cellular uptake into an organ of interest. Using this technique, nanoparticles reach the interior of dense tumors and are selectively taken up by lung cancer cells. Importantly, this surgical approach is essential as the same nanoparticles do not reach lung tumor cells upon systemic or intratracheal administration. Organ-restricted vascular delivery thus opens up new avenues for optimized nanotherapies for cancer and other diseases.

pharmacology and toxicology↗